SARAH BANKS: Open Payments
NPI 1487278735 · MT STERLING, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,041 in 58 payments from 13 companies in 2025. Trend: 2023 $578 · 2024 $559 · 2025 $1,041
Food & beverage: $1,041
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 15 | $212 |
| Vanda Pharmaceuticals Inc. | 10 | $192 |
| ABBVIE INC. | 8 | $157 |
| Indivior Inc. | 6 | $105 |
| GlaxoSmithKline, LLC. | 5 | $104 |
| Otsuka America Pharmaceutical, Inc. | 3 | $60 |
| Lilly USA, LLC | 3 | $49 |
| AstraZeneca Pharmaceuticals LP | 2 | $40 |
| Janssen Pharmaceuticals, Inc | 2 | $39 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $27 |
Products named: CAPLYTA, VRAYLAR, HETLIOZ, SUBLOCADE, TRELEGY ELLIPTA, FANAPT, REXULTI, MOUNJARO.
Industry payments across KY — which companies pay providers there.
